Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BYBiosensors

Ultrasonographic and Electromyographic Evaluation of the Effects of Deep Versus Superficial Dry Needling on Myofascial Trigger Points in Patients with Neck Pain: A Triple-Blind Randomized Clinical Trial.

  1. 1Department of Physical Therapy, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
  2. 2Department of Medical Imaging, Qatif Health Network, Qatif 32654, Saudi Arabia.
  3. 3Department of Medical Imaging, Prince Mohammed Bin Fahad Hospital of Blood Disorder, Qatif 32643, Saudi Arabia.

Abstract

Background: The physiological differences between deep dry needling (DDN) and superficial dry needling (SDN) for myofascial trigger points (MTrPs) remain unclear. This randomized clinical trial compared the impact of DDN and SDN on ultrasonographic, surface electromyographic (sEMG), and clinical outcomes in patients with non-specific neck pain and upper trapezius MTrPs. Methods: Forty-four participants were randomly allocated to DDN (50 mm) or SDN (13 mm), with 22 participants in each group. Participants received four treatment sessions over 2 weeks. Ultrasonographic outcomes included upper trapezius stiffness, thickness, and blood-flow parameters. sEMG outcomes included maximum voluntary isometric contraction (MVIC), root mean square (RMS), and median frequency (MDF). Pain intensity was measured using the Visual Analogue Scale (VAS) and disability using the Neck Disability Index (NDI). Outcomes were assessed at baseline, following 2 weeks of intervention, and during the 6-week follow-up. Results: No statistically significant between-group differences were detected for the ultrasonographic outcomes. For sEMG, the time-specific contrast for active RMS at the 6-week follow-up was nominally significant (DDN minus SDN: 1.09, 95% CI 0.06-2.13; p = 0.039), whereas the remaining between-group sEMG comparisons were not statistically significant. A small within-group reduction in muscle stiffness was observed in the SDN group at 2 weeks (-0.09, 95% CI -0.17 to -0.001). MVIC increased in both groups at 6 weeks, and active RMS decreased within the SDN group. Both groups showed reductions in pain and disability; adjusted VAS changes ranged from -3.04 to -3.35 cm and adjusted NDI changes ranged from -4.5 to -6.5 points across groups and follow-up assessments. The isolated p = 0.039 finding is interpreted cautiously because multiple outcomes were examined without formal multiplicity adjustment. Conclusions: Both DDN and SDN were associated with improvements in pain and disability, with no statistically significant between-group differences detected for these clinical outcomes in this sample. Most ultrasonographic and sEMG between-group comparisons were also non-significant, although a nominal difference in active RMS was observed at 6 weeks. Because this trial was not designed as an equivalence or non-inferiority study, the findings should not be interpreted as establishing therapeutic equivalence. The absence of consistent ultrasonographic changes suggests that mechanisms beyond measurable local structural or vascular changes may contribute to the observed clinical improvements; such mechanisms were not directly measured in this study.

Related

  1. Effects of myofascial release on clinical outcomes and muscle viscoelastic properties in patients with breast cancer: A randomized controlled trial
    Özlem Feyzioğlu, Selvi Dinçer, Özgül Öztürk +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textCell biologyCrossref
  2. Comparison of two repetitive peripheral magnetic stimulation protocols for upper trapezius myofascial pain syndrome: A randomized trial
    Thitirut Jongutchariya, Surapa Hangsaphruek, Thawisak Wongkiratimethawi +1
    PLOS OnePeer-reviewedCC BY 4.0Full textNeurosciencePLOS
  3. Can non-invasive surface measurements predict abdominal wall myofascial mechanics? An exploratory study
    Grégoire Deshairs, Arthur Jourdan, Catherine Masson +2
    Multidisciplinary Biomechanics JournalPeer-reviewedCC BY 4.0Full textCell biologyHAL
  4. Superficial spinal Tac1-lineage neurons are polymodal nociceptive
    L. Brochoire, P. Larque, X. Zhang +5
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  5. Transcriptomic profile of a rat jaw opener (anterior digastric) and a jaw closer (superficial masseter).
    P. S. Meemaduma, B. P. Reder, N. Konow +2
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
BibTeX
@article{alhakami2026ultrasonographic,
  title = {{Ultrasonographic and Electromyographic Evaluation of the Effects of Deep Versus Superficial Dry Needling on Myofascial Trigger Points in Patients with Neck Pain: A Triple-Blind Randomized Clinical Trial.}},
  author = {Anas Mohammed Alhakami and Diyaa Abdul Rauf Algazwi and Majdi Habib Al-Awjami and Walaa Hamdy Elsayed and Ali M Alshami},
  journal = {Biosensors},
  year = {2026},
  month = oct,
  doi = {10.3390/bios16100583},
  url = {https://europepmc.org/article/MED/42930130},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Ultrasonographic and Electromyographic Evaluation of the Effects of Deep Versus Superficial Dry Needling on Myofascial Trigger Points in Patients with Neck Pain: A Triple-Blind Randomized Clinical Trial.
AU  - Anas Mohammed Alhakami
AU  - Diyaa Abdul Rauf Algazwi
AU  - Majdi Habib Al-Awjami
AU  - Walaa Hamdy Elsayed
AU  - Ali M Alshami
PY  - 2026
DA  - 2026/10/18
JO  - Biosensors
DO  - 10.3390/bios16100583
UR  - https://europepmc.org/article/MED/42930130
AB  - Background: The physiological differences between deep dry needling (DDN) and superficial dry needling (SDN) for myofascial trigger points (MTrPs) remain unclear. This randomized clinical trial compared the impact of DDN and SDN on ultrasonographic, surface electromyographic (sEMG), and clinical outcomes in patients with non-specific neck pain and upper trapezius MTrPs. Methods: Forty-four participants were randomly allocated to DDN (50 mm) or SDN (13 mm), with 22 participants in each group. Participants received four treatment sessions over 2 weeks. Ultrasonographic outcomes included upper trapezius stiffness, thickness, and blood-flow parameters. sEMG outcomes included maximum voluntary isometric contraction (MVIC), root mean square (RMS), and median frequency (MDF). Pain intensity was measured using the Visual Analogue Scale (VAS) and disability using the Neck Disability Index (NDI). Outcomes were assessed at baseline, following 2 weeks of intervention, and during the 6-week follow-up. Results: No statistically significant between-group differences were detected for the ultrasonographic outcomes. For sEMG, the time-specific contrast for active RMS at the 6-week follow-up was nominally significant (DDN minus SDN: 1.09, 95% CI 0.06-2.13; p = 0.039), whereas the remaining between-group sEMG comparisons were not statistically significant. A small within-group reduction in muscle stiffness was observed in the SDN group at 2 weeks (-0.09, 95% CI -0.17 to -0.001). MVIC increased in both groups at 6 weeks, and active RMS decreased within the SDN group. Both groups showed reductions in pain and disability; adjusted VAS changes ranged from -3.04 to -3.35 cm and adjusted NDI changes ranged from -4.5 to -6.5 points across groups and follow-up assessments. The isolated p = 0.039 finding is interpreted cautiously because multiple outcomes were examined without formal multiplicity adjustment. Conclusions: Both DDN and SDN were associated with improvements in pain and disability, with no statistically significant between-group differences detected for these clinical outcomes in this sample. Most ultrasonographic and sEMG between-group comparisons were also non-significant, although a nominal difference in active RMS was observed at 6 weeks. Because this trial was not designed as an equivalence or non-inferiority study, the findings should not be interpreted as establishing therapeutic equivalence. The absence of consistent ultrasonographic changes suggests that mechanisms beyond measurable local structural or vascular changes may contribute to the observed clinical improvements; such mechanisms were not directly measured in this study.
SN  - 2079-6374
ER  -